Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01778 is a long intergenic non-coding RNA gene identified in the human genome, characterized by the absence of protein-coding potential and location between known genes[1][3]. LINC01778 produces RNA transcripts longer than 200 nucleotides, typical of lincRNAs, which often function in chromatin regulation, transcriptional control, and modulation of gene expression, usually in a tissue-specific and context-dependent manner[5]. Although the general family of lincRNAs has been linked to roles in cancer, development, and disease, specific biological functions, disease associations, and interacting molecules for LINC01778 itself are not defined at present[1][3][5]. It remains a subject primarily of basic genomic annotation and functional genomics study.
None. There are no known drugs, chemical probes, or therapeutic interventions targeting LINC01778.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1778 (LINC01778).